BVT Knock-Out ALGN/ DE000VD2K9N4 /
6/10/2024 9:47:22 AM | Chg.+0.06 | Bid11:04:51 AM | Ask11:00:20 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
3.34EUR | +1.83% | 3.31 Bid Size: 4,000 |
- Ask Size: - |
Align Technology Inc | 220.80 USD | 12/31/2078 | Call |
GlobeNewswire
11:00 AM
Rhino Health to Deliver Enterprise Federated Computing Solutions in Collaboration With NVIDIA
GlobeNewswire
11:00 AM
VEON and Kyivstar increase Ukraine investment commitment to USD 1 billion, attend Ukraine Recovery C...
GlobeNewswire
11:00 AM
Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Tr...
GlobeNewswire
10:00 AM
Master the Complexities of International Mergers & Acquisitions with IBFD's New Online Course!
GlobeNewswire
10:00 AM
SiSaf’s Bio-Courier Technology Enables Clinical Trial Success for Topical Treatment of Mild to Moder...
GlobeNewswire
10:00 AM
SHCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sharecare Inc. Investors with ...
GlobeNewswire
10:00 AM
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Sub...
GlobeNewswire
7:30 AM
Viridien launches new brand to accelerate growth as an advanced technology company
GlobeNewswire
7:00 AM
Santhera Announces Launch of Early Access Program in China for AGAMREE® by its Partner Sperogenix
GlobeNewswire
7:00 AM
Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith...
GlobeNewswire
6:05 AM
Food Logistics Names Covenant Logistics Group as Recipient of 2024 Top 3PL & Cold Storage Providers ...
GlobeNewswire
3:00 AM
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
1:37 AM
FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application f...